American Well EBITDA Margin 2019-2025 | AMWL
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for American Well (AMWL) over the last 10 years. The current EBITDA margin for American Well as of March 31, 2025 is .
| American Well EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-03-31 | $0.26B | $-0.14B | -52.67% |
| 2024-12-31 | $0.26B | $-0.18B | -71.37% |
| 2024-09-30 | $0.26B | $-0.20B | -76.86% |
| 2024-06-30 | $0.26B | $-0.21B | -83.59% |
| 2024-03-31 | $0.26B | $-0.23B | -89.80% |
| 2023-12-31 | $0.26B | $-0.22B | -85.71% |
| 2023-09-30 | $0.27B | $-0.23B | -86.89% |
| 2023-06-30 | $0.27B | $-0.24B | -87.59% |
| 2023-03-31 | $0.28B | $-0.24B | -87.73% |
| 2022-12-31 | $0.28B | $-0.25B | -89.17% |
| 2022-09-30 | $0.27B | $-0.23B | -84.50% |
| 2022-06-30 | $0.26B | $-0.22B | -81.44% |
| 2022-03-31 | $0.26B | $-0.19B | -72.20% |
| 2021-12-31 | $0.25B | $-0.16B | -63.24% |
| 2021-09-30 | $0.24B | $-0.17B | -69.17% |
| 2021-06-30 | $0.24B | $-0.18B | -73.44% |
| 2021-03-31 | $0.25B | $-0.23B | -91.20% |
| 2020-12-31 | $0.25B | $-0.22B | -87.40% |
| 2020-06-30 | $0.16B | $-0.13B | -84.81% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.129B | $0.254B |
| American Well Corp provides telehealth platform principally in the United States and globally. American Well Corp is based in BOSTON. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.937B | 59.72 |
| Hims & Hers Health (HIMS) | United States | $13.490B | 140.16 |
| Doximity (DOCS) | United States | $11.213B | 51.91 |
| Tempus AI (TEM) | United States | $10.091B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.366B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.822B | 59.72 |
| Hinge Health (HNGE) | United States | $3.402B | 0.00 |
| Privia Health (PRVA) | United States | $2.375B | 162.33 |
| 10x Genomics (TXG) | United States | $1.724B | 0.00 |
| Phreesia (PHR) | United States | $1.614B | 0.00 |
| Enovis (ENOV) | United States | $1.561B | 8.70 |
| Schrodinger (SDGR) | United States | $1.553B | 0.00 |
| Azenta (AZTA) | United States | $1.553B | 72.17 |
| Clover Health Investments (CLOV) | United States | $1.471B | 0.00 |
| Omnicell (OMCL) | United States | $1.387B | 24.48 |
| Evolent Health (EVH) | United States | $1.105B | 94.10 |
| Claritev (CTEV) | United States | $0.635B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.535B | 0.00 |
| Standard BioTools (LAB) | United States | $0.528B | 0.00 |
| Veradigm (MDRX) | United States | $0.503B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.453B | 0.00 |
| Talkspace (TALK) | United States | $0.420B | 125.50 |
| TruBridge (TBRG) | United States | $0.328B | 728.00 |
| Outset Medical (OM) | United States | $0.311B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.273B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.255B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.218B | 0.00 |
| CapsoVision (CV) | United States | $0.210B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.182B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.161B | 0.00 |
| Pulmonx (LUNG) | United States | $0.124B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.122B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.117B | 0.00 |
| CareCloud (CCLD) | United States | $0.100B | 3.82 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.079B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.078B | 0.00 |
| 111 (YI) | China | $0.060B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.042B | 0.00 |
| HeartBeam (BEAT) | United States | $0.041B | 0.00 |
| Zhongchao (ZCMD) | China | $0.025B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| PROFUSA (PFSA) | United States | $0.005B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |